Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Interleukin-6 (IL-6) Receptor Antagonists and IL6- Inhibitors" report has been added to ResearchAndMarkets.com's offering. This competitive ...
(MENAFN- GlobeNewsWire - Nasdaq) The IL-6 receptor antagonist market presents significant opportunities in underexplored areas like thyroid eye disease and atherosclerotic cardiovascular disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback